Showing results (481-490 of 1,373) with videos related to

Sort By:
Pageof 138
Drug Development Research|September 1, 2022
Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activationQianjin Zhang, Yichuan Hu, Jin-E Hu, et al.
Drug Development Research|April 20, 2019
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastaseMaria P Giovannoni, Niccolò Cantini, Letizia Crocetti, et al.
Drug Development Research|September 27, 2021
Exploration of novel TOSMIC tethered imidazo[1,2-a]pyridine compounds for the development of potential antifungal drug candidatePratibha Shukla, Deepa Deswal, Mansi Pandit, et al.
Drug Development Research|November 2, 2021
Structure and activity of an anti-epidermal growth factor receptor antibody without galactose-α-1,3-galactose residuesKeyun Ren, Hao Gong, Zheng Ma, et al.
Drug Development Research|February 8, 2022
Daphnetin inhibits the survival of hepatocellular carcinoma cells through regulating Wnt/β-catenin signaling pathwayChaohui Liu, Jiansheng Pan, Hongyu Liu, et al.
Drug Development Research|January 28, 2022
Effect of interferon regulatory factor 2 on inflammatory response and oxidative stress in lipopolysaccharide-induced acute kidney injuryTianwei He, Lina Yang, Daoxu Wu
Drug Development Research|January 29, 2022
Autophagic and apoptotic cell death induced by the quinoline derivative 2-(6-methoxynaphthalen-2-yl)quinolin-4-amine in pancreatic cancer cells is via ER stress and inhibition of Akt/mTOR signaling pathwayHabeebunnisa Begum, Nagaraju Chirra, Dinesh Kumar, et al.
Drug Development Research|April 25, 2022
Xanthatin inhibits non-small cell lung cancer proliferation by breaking the redox balanceYanbo Xie, Xueyu Zhu, Ping Liu, et al.
Drug Development Research|March 17, 2022
Benzimidazole-carbamate anthelmintics: Perspective candidates for the anticancer drug developmentParteek Prasher, Mousmee Sharma
Drug Development Research|September 7, 2018
Evaluation of samidorphan, a μ-opioid antagonist, in a drug discrimination assay in ratsMario P Sgro, Deah L Modlin, Daniel R Deaver, et al.
Pageof 138